About Serine protease hepsin
Serine protease hepsin (HPN) is a protein
from Homo sapiens identified by UniProt accession
P05981, 417 residues long.
MolForge cross-references it against 0 known binders and
157 disease associations.
Target properties
| Protein name | Serine protease hepsin |
| UniProt accession | P05981 |
| Gene | HPN |
| Organism | Homo sapiens |
| Length | 417 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (7)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (157)
Diseases linked to this target (Open Targets).
- serum albumin measurement · score 0.46
- sex hormone-binding globulin measurement · score 0.41
- triglyceride measurement · score 0.39
- C-reactive protein measurement · score 0.38
- calcium measurement · score 0.37
- testosterone measurement · score 0.37
- total blood protein measurement · score 0.37
- urinary albumin to creatinine ratio · score 0.35
- alkaline phosphatase measurement · score 0.34
- platelet count · score 0.34
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P05981-F1 | alphafold | PREDICTED | 91.12 | — |
Amino-acid sequence (417 residues)
MAQKEGGRTV PCCSRPKVAA LTAGTLLLLT AIGAASWAIV AVLLRSDQEP LYPVQVSSAD ARLMVFDKTE GTWRLLCSSR SNARVAGLSC EEMGFLRALT HSELDVRTAG ANGTSGFFCV DEGRLPHTQR LLEVISVCDC PRGRFLAAIC QDCGRRKLPV DRIVGGRDTS LGRWPWQVSL RYDGAHLCGG SLLSGDWVLT AAHCFPERNR VLSRWRVFAG AVAQASPHGL QLGVQAVVYH GGYLPFRDPN SEENSNDIAL VHLSSPLPLT EYIQPVCLPA AGQALVDGKI CTVTGWGNTQ YYGQQAGVLQ EARVPIISND VCNGADFYGN QIKPKMFCAG YPEGGIDACQ GDSGGPFVCE DSISRTPRWR LCGIVSWGTG CALAQKPGVY TKVSDFREWI FQAIKTHSEA SGMVTQL
Explore Serine protease hepsin with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets